-+ 0.00%
-+ 0.00%
-+ 0.00%

Apellis Pharmaceuticals Earnings Report: Q4 Overview

Benzinga·02/24/2026 12:08:12
Listen to the news

Apellis Pharmaceuticals (NASDAQ:APLS) reported its Q4 earnings results on Tuesday, February 24, 2026 at 07:05 AM.

Here's what investors need to know about the announcement.

Earnings

Apellis Pharmaceuticals missed estimated earnings by -20.51%, reporting an EPS of $-0.47 versus an estimate of $-0.39.

Revenue was down $12.62 million from the same period last year.

Overview of Past Earnings

The company beat on EPS by $0.69 in the previous quarter, leading to a 3.57% increase share price change the next day.

Here's a look at Apellis Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.98 -0.46 -0.34 -0.40
EPS Actual 1.67 -0.33 -0.74 -0.29
Revenue Estimate 391.98M 188.42M 197.60M 197.91M
Revenue Actual 458.58M 178.49M 166.80M 212.53M

To track all earnings releases for Apellis Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.